Lung Cancer News

The addition of stereotactic body radiotherapy to immune checkpoint inhibitors failed to significantly extend survival among individuals with advanced solid tumors, results of the randomized phase 2 CHEERS trial showed.

People living with HIV and various cancer types may be safely treated with immune checkpoint inhibitors, according to results of a retrospective study published in Journal of Clinical Oncology.

Datopotamab deruxtecan improved PFS compared with standard chemotherapy for patients with advanced non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

Cardiorespiratory fitness levels appeared associated with cancer risk and mortality among a cohort of Swedish men, according to study results published in JAMA Network Open.

The FDA announced several regulatory actions the past few weeks.

More than one-third of adults with previously untreated stage III non-small cell lung cancer exhibited a pathologic complete response after receiving perioperative nivolumab plus chemotherapy, results of a randomized phase 2 trial showed.

Compared with white veterans, Black veterans had a reduced likelihood of carrying out a lung cancer screening referral, according to study results published in JAMA Network Open.

In this interview, Charu Aggarwal, MD, MPH, discusses results from ADAURA trial presented at this year’s ASCO Annual Meeting.

Healio spoke with Karen L. Reckamp, MD, professor in medicine and director of the division of medical oncology at Cedars-Sinai Medical Center, about key studies in lung cancer from ASCO Annual Meeting.

Healio spoke with Karen L. Reckamp, MD, about research on perioperative lung cancer presented at ASCO Annual Meeting.